SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Timothy Fox was appointed as Chief Financial Officer effective August 11, 2026, with a $399,000 base salary, 80% target bonus, and $1.5 million in equity grants (RSUs and PSUs), bringing 35+ years of finance experience and prior roles at the company.
View raw filing on EDGAR →The filing discloses the promotion of Jon Osborne to Chief Commercial Officer, effective August 6, 2026. This is a material executive appointment to a C-suite position with broad responsibility for "all elements of Shoulder Innovations' commercial organization." The press release emphasizes his strategic importance to the company's commercial execution and growth strategy, making this a material governance event affecting investor assessment of leadership and commercial direction.
View raw filing on EDGAR →Craig Abrahams was elected as a Class I director and appointed to the Audit Committee, effective August 10, 2026. While the disclosure also mentions his participation in the Non-Employee Director Compensation Policy with RSU grants totaling approximately $585,000 in grant date fair value, the principal disclosed action is the appointment of a new director to the board and a committee. This is a material governance event affecting board composition.
View raw filing on EDGAR →Robert R. "Rusty" Hutson, Jr. was appointed as Chairman of the Board effective August 5, 2026, assuming the dual role of CEO and Chairman. The filing also notes additional board updates including new Lead Independent Director and Compensation Committee appointments.
View raw filing on EDGAR →Cary Baetz was appointed as Executive Vice President and Chief Financial Officer effective August 12, 2026, with detailed compensation arrangements including base salary of $500,000 and equity grants totaling approximately $2.625 million. Andrew Judge was also appointed as Senior Vice President of Finance. The appointment of new senior financial leadership is material to investors assessing the company's financial management and capital allocation.
View raw filing on EDGAR →The filing discloses the appointment of George L. Nash, Jr. as a director of Granite Construction Incorporated, effective August 5, 2026. The principal disclosed action is a person taking a role on the Board, with assignment to the Audit/Compliance Committee and Risk Committee. While the disclosure mentions standard director compensation arrangements, the core event is the appointment itself, making this an exec_appointment rather than exec_compensation.
View raw filing on EDGAR →The filing discloses the appointment of Derek Liu as Chief Accounting Officer, effective August 7, 2026, pursuant to an offer letter dated August 6, 2026. The principal disclosed action is a person taking a role (CAO), making this an executive appointment. The disclosure includes his background, compensation terms ($350,000 base salary plus 50% target bonus), and eligibility for long-term incentives, which is material to investors assessing the company's financial leadership.
View raw filing on EDGAR →The exhibit discloses multiple executive leadership changes effective July 30 and September 30, 2026, including the appointment of Dan Myerson as Chair, Christian Milau as President and CEO, Tamiko Ohta as Senior Vice President Legal and General Counsel, and Paul Ferneyhough's expanded role as EVP Strategy and CFO. While the filing also includes departures (Steven Reid, George Burns, Frank Herbert, Louw Smith), the principal disclosed actions are the appointments and assumption of new roles by named executives, making exec_appointment the best fit. The confidence is moderate (0.75) because the filing bundles multiple concurrent departures and appointments; a strict reading could support exec_departure for Reid and Burns, but the material change report emphasizes the Board and management succession process and the new appointments.
View raw filing on EDGAR →The exhibit announces the appointment of Ms. Simin Ren as sole Chief Executive Officer and Chairperson of the Board, and Mr. Jie Gao as Vice President of Investment and director, effective August 6–7, 2026. Although Mr. Shaojie Chen's resignation as CEO and director is also disclosed, the principal disclosed action is the appointment of new leadership to fill those roles. The Company states it does not expect material adverse effects, but executive succession at the CEO and board level is material to investors assessing governance and continuity.
View raw filing on EDGAR →Michael D. Ruppert was appointed to the Board of Directors as a Class II director effective August 5, 2026, bringing 25+ years of aerospace and defense financial and strategic experience as ManTech's CFO. Concurrently, director Charles Thomas Burbage retired from the Board effective at the 2026 Annual Meeting. The Board expanded from 9 to 10 directors to accommodate the new appointment.
View raw filing on EDGAR →Michael George was appointed as Interim Chief Executive Officer effective on the Plan Effective Date, with compensation of $1.5M base salary and a $5M initial equity award with performance conditions, replacing David Rawlinson II. Eight new directors were also appointed to replace eight departing directors, with new board committees and compensation arrangements established.
View raw filing on EDGAR →The filing discloses the appointment of Mr. Kunqi Bai as a director of JIADE LIMITED on August 7, 2026, to fill a vacancy created by the resignation of Mr. Xiaohui Li (who was also Joint-Chief Executive Officer). While both a departure and appointment occur, the principal disclosed action is the board's appointment of a new director, making exec_appointment the primary classification. The appointment of a director is material to investors assessing the company's governance and leadership structure.
View raw filing on EDGAR →The disclosure centers on the election of Anthony Jabbour as a director effective August 5, 2026, with appointment to the Audit and Risk Committees. While the section also mentions compensation arrangements, the principal action disclosed is the appointment of a new director to the board, making this an exec_appointment event. The appointment of an experienced executive (former CEO of Dun & Bradstreet and Black Knight) to a major insurer's board is material to investors.
View raw filing on EDGAR →The filing discloses the election of Danny Deep, the current president of General Dynamics, to the board of directors effective August 5, 2026. This is a clear executive appointment to a governance role. While Deep already serves as president and receives no additional compensation for the board seat, the principal disclosed action is his appointment as a director, which is material to investors as it reflects board composition changes and governance structure at a major defense contractor.
View raw filing on EDGAR →The 6-K discloses the appointment of two new directors effective August 7, 2026: Ms. Hsu Hui Chen as director and co-chief executive officer, and Ms. Lim Fei Fern as independent director and chairperson of the Compensation Committee. While the filing also reports concurrent resignations of three directors (Wu Wai Kong, Mhlengi Prevail Mafu, and Chung Wai Wong), the principal disclosed action is the appointment of the new directors to fill those vacancies, making this an exec_appointment event. The appointment of a co-CEO and multiple committee members is material to investor assessment of governance and leadership.
View raw filing on EDGAR →The filing discloses the Board's unanimous appointment of Ben Wiesenfeld as Chief Compliance Officer effective August 3, 2026, succeeding Scott Betz. While Betz transitions to Chief Operating Officer, the principal disclosed action centers on Wiesenfeld's appointment to the CCO role. As a BDC, compliance officer appointments are material governance events affecting investor assessment of regulatory oversight and internal controls.
View raw filing on EDGAR →The 6-K announces the appointment of three independent directors (Chan Kelvin Zhi Hong, Lee Chee Wai, and Wong Khai Meng) effective August 5, 2026, with detailed biographies and committee assignments. While the filing also discloses three concurrent director resignations, the principal disclosed action is the appointment of new directors to the Board and reconstitution of board committees, which is material to investors' assessment of governance and board composition.
View raw filing on EDGAR →The news release announces that Joseph Natale will succeed Scott Powers as Chair of the Board of Directors following Sun Life's Annual General Meeting in May 2027. While the release also discloses Powers' retirement, the principal disclosed action is Natale's appointment to the chair role—a material governance event for a major financial services company. The appointment of a new board chair is material to investors assessing leadership and governance quality.
View raw filing on EDGAR →William List was appointed by the Board as Chief Financial Officer effective September 1, 2026, following Federal Housing Finance Agency non-objection. The disclosure centers on his appointment to this principal financial officer role, his compensation package (base salary of $432,957 and incentive award eligibility), and his background. While the filing also mentions Edward V. Weller's transition to Executive Senior Advisor, the principal disclosed action is List's appointment to the CFO position.
View raw filing on EDGAR →The filing discloses two executive appointments effective August 10, 2026: Andrew C. Wiechmann was appointed to serve as interim principal accounting officer (in addition to his CFO role), and Kristine Johnson was appointed as interim Global Controller. While the filing references a prior departure of the Global Controller and Chief Accounting Officer (disclosed March 31, 2026), the principal action disclosed here is the appointment of successors to fill those roles on an interim basis. The appointments of two officers to key accounting and financial reporting positions are material to investors' assessment of the company's financial controls and reporting infrastructure.
View raw filing on EDGAR →The filing discloses the appointment of Andrey Mushakov to Executive Vice President & Chief Operating Officer on August 6, 2026, a promotion from his prior role as Executive Vice President, Nuclear Operations. While the section also includes compensatory arrangements (RSA Grants), the principal disclosed action centers on the appointment to a material C-suite position. The appointment is material as it represents a significant change in executive leadership and operational responsibility.
View raw filing on EDGAR →The filing discloses the appointment of two new directors, Peter Martin Rozenauers and Kevin McQuilkin, to Uranium Royalty Corp.'s Board of Directors effective immediately on August 7, 2026. The Board was expanded from six to eight directors to accommodate these appointments. This is a clear executive appointment event under Item 5.02, with material significance given that one appointee (Rozenauers) is affiliated with Orion Sellers, who beneficially own more than 40% of the company's outstanding shares.
View raw filing on EDGAR →Pinterest appointed Renee Jewell as Chief Accounting Officer effective August 26, 2026. While the disclosure includes compensatory details (base salary of $450,000, sign-on bonus of $225,000, RSU award of $2,550,000, and target annual bonus), the principal disclosed action is the appointment of a named executive officer to a material accounting leadership role. The compensation is ancillary to the appointment itself.
View raw filing on EDGAR →The Board of Directors elected Antony F. Spring, currently Chairman and CEO of Macy's, Inc., as a director of Aramark on August 4, 2026. This is a clear executive appointment to the Board, with the filing disclosing his background, roles, and eligibility for director compensation. The appointment of a prominent external executive to the board is material to investors assessing governance and strategic direction.
View raw filing on EDGAR →The filing discloses the appointment of James Sellers as Chief Executive Officer effective December 26, 2026, succeeding retiring CEO Stanley Linville. While the section covers both a departure (Linville's retirement) and an appointment (Sellers' succession), the principal disclosed action centers on the appointment of the new CEO with detailed biographical information, employment agreement terms, and compensation arrangements. The appointment of a new CEO is material to investors' assessment of company leadership and governance.
View raw filing on EDGAR →The filing discloses the appointment of John Yetimoglu as a director of Biohaven Ltd., effective August 6, 2026, and his appointment to the Nominating and Governance Committee. While the disclosure also includes compensatory details (options with $713,875 grant date fair value and a $57,000 annual retainer), the principal disclosed action is the director appointment itself, making this an exec_appointment event. Director appointments are material to investors as they affect board composition and governance.
View raw filing on EDGAR →Arrow Electronics appointed Deidra C. Merriwether as President and Chief Operating Officer, effective September 8, 2026, with a base salary of $900,000, target incentive awards, and substantial equity grants totaling approximately $9.5 million.
View raw filing on EDGAR →The Board unanimously appointed Wade M. Jenke as CEO and President, Sui Man Ho as CFO, and Joseph Haughawout as COO, effective August 6, 2026, representing a significant management transition at the principal executive officer and key officer levels.
View raw filing on EDGAR →Bausch & Lomb appointed four new directors effective August 5, 2026: Thomas J. Appio (CEO of parent company Bausch Health), Robert Chersi, Laurence Paul, M.D., and Barbara Trebbi, at the request of controlling shareholder Bausch Health Companies Inc. The appointments represent a significant governance change and board restructuring.
View raw filing on EDGAR →The 6-K furnishes Exhibit 1, a press release titled "BAT Announces Management Board Changes" dated August 6, 2026. While the body of the 6-K itself contains no substantive disclosure, the exhibit index explicitly references a management board changes announcement. Management board changes typically involve executive appointments, departures, or both. Given the title and the materiality of such changes to a major multinational corporation, this disclosure is classified as an executive appointment or departure event. The confidence is slightly moderated because the actual content of the management changes is not reproduced in the body text provided, but the exhibit title is unambiguous.
View raw filing on EDGAR →The press release announces the appointment of James Bannantine as Co-Chief Executive Officer of Largo Inc., effective immediately. While the release also mentions Daniel Tellechea's retirement from the Co-CEO role, the principal disclosed action is Bannantine's appointment to a named executive officer position. The appointment is material because it represents a significant senior leadership transition at the company's highest level, with Bannantine bringing substantial turnaround and operational expertise relevant to Largo's strategic priorities.
View raw filing on EDGAR →The exhibit announces the appointment of Catherine McLeod-Seltzer to IAMGOLD's board of directors effective September 1, 2026. This is a clear governance event involving the appointment of a director with substantial mining industry experience and track record, which would be material to a reasonable investor's assessment of the company's leadership and strategic direction.
View raw filing on EDGAR →The exhibit announces Peter Zebedee's appointment as President and Chief Financial Officer effective September 14, 2026, and his planned appointment as President and Chief Executive Officer in April 2027, following a rigorous Board succession process. While Rich Kruger's transition to Executive Vice Chair also occurs, the principal disclosed action is Peter's appointment to these senior executive roles. The announcement also includes appointments of Adam Albeldawi as Executive Vice President Upstream and Shelley Powell as Executive Vice President Development and Projects, all material leadership changes at a major energy company.
View raw filing on EDGAR →The filing discloses the appointment of Rahul Singhal as Chief Executive Officer and Principal Executive Officer effective September 30, 2026, along with his election to the Board of Directors. While the filing also mentions Jack Abuhoff's transition from CEO to Executive Chairman, the principal disclosed action centers on Singhal's appointment to the CEO role and board membership. This is a material executive succession event at a public company with strong recent financial performance (58% YoY revenue growth, record results).
View raw filing on EDGAR →Anthony J. Salgado was appointed Chief Operating Officer of Hyster-Yale, Inc. effective August 1, 2026, representing a material executive appointment. Although Mr. Salgado previously served as President and CEO of the principal operating subsidiary, his elevation to COO at the parent company level is a significant leadership change that would affect investor assessment of the company's governance and operational structure.
View raw filing on EDGAR →Sharon Binger was appointed as a Class I director effective August 6, 2026 and simultaneously appointed to the Nominating and Corporate Governance Committee, with the Board increasing its size to nine directors to accommodate this appointment.
View raw filing on EDGAR →Arteris, Inc. appointed Saurabh Sinha as Chief Financial Officer, effective September 8, 2026, succeeding retiring CFO Nick Hawkins. The appointment includes compensatory arrangements comprising a base salary of $440,000, target bonus of 60%, and equity awards totaling approximately $5.7 million in PSUs and RSUs.
View raw filing on EDGAR →Warren Foust was appointed President, Chief Executive Officer, and Board member effective August 4, 2026, following an extensive global search. Deborah Andrews transitioned from Interim Co-CEO to Executive Vice President and Chief Financial Officer. The appointment includes substantial compensation arrangements including a base salary of $730,000 and significant equity grants.
View raw filing on EDGAR →On August 5, 2026, the Board appointed Ziad Ghanem, the Company's President and CEO since March 2023, to serve as a member of the Board, effective immediately, with no additional compensation.
View raw filing on EDGAR →David Turner was elected to the Board of Directors effective August 3, 2026, filling a newly created director position as a Class II director.
View raw filing on EDGAR →James Saccaro's appointment as Executive Vice President, Chief Financial Officer and Chief Operating Officer effective August 17, 2026 is the principal disclosed action. While the filing also discloses Wetteny Joseph's departure, the appointment of a new CFO/COO at a major public company (Zoetis, a large-cap animal health leader) is the salient event. The compensation details (base salary $1M, LTI target $5M, make-whole awards totaling $7.5M) and his extensive background at GE HealthCare and Baxter underscore the materiality of this executive leadership transition.
View raw filing on EDGAR →Douglas Murray was elected to the Board of Directors on August 3, 2026, effective immediately. Murray is an enterprise networking and security veteran with 30 years of experience at companies including Juniper Networks and Extreme Networks, and is the current CEO of Auvik.
View raw filing on EDGAR →TCGX Acquisition Corp. appointed three independent directors—Andrew Cheng, M.D., Ph.D., Ying Huang, Ph.D., and Wei Lin, M.D.—to the Board effective August 4, 2026, in connection with the IPO, establishing the initial board composition and governance structure of the newly public SPAC.
View raw filing on EDGAR →The filing discloses the appointment of Lionel F. Conacher, the Company's Chairman, as Interim Chief Executive Officer effective August 12, 2026, following the retirement of Harvey S. Kanter. While the section also covers Kanter's departure, the principal disclosed action centers on Conacher's appointment to the CEO role, supported by detailed compensation terms ($80,000/month base salary plus $15,000/month in equity) and governance changes (appointment of Lead Independent Director, committee reassignments). This is a material executive appointment at a critical juncture for the company.
View raw filing on EDGAR →The filing discloses the appointment of Scott E. Zoellner as a director of Saratoga Investment Corp., effective immediately on August 5, 2026. The Board increased from five to six members and appointed Mr. Zoellner to the audit, compensation, and nominating and corporate governance committees. This is a clear executive appointment under Item 5.02, and the addition of an independent director with significant private equity and capital markets experience is material to investors' assessment of the company's governance and oversight.
View raw filing on EDGAR →Arbe Robotics appointed Assaf Pereg, CPA, as Chief Financial Officer, effective August 30, 2026, succeeding departing CFO Karine Pinto-Flomenboim.
View raw filing on EDGAR →The press release announces the appointment of Daniel Brau as Chief Quantum Officer (CQO), a newly created executive role. The appointment is material because it represents a significant strategic leadership decision tied to the company's quantum commercialization strategy, with Brau given a mandate to lead strategic and commercial development of the SEALQuantum ecosystem and drive revenue generation across the quantum portfolio. This is a clear executive appointment disclosure.
View raw filing on EDGAR →The filing discloses the appointment of Dr. Christopher Kim as Chief Scientific Officer, effective immediately on August 5, 2026. As CSO, he will lead scientific, clinical, and regulatory development of the Company's primary APITOX program. This is a material executive appointment to a senior leadership role overseeing the company's core development strategy and regulatory pathway.
View raw filing on EDGAR →The filing discloses that the Central Bank of the Argentine Republic (BCRA) has authorized María Soledad Duro Ruiz to serve as a Director of Banco BBVA Argentina S.A., following her designation by the shareholders' assembly. This is a director appointment requiring regulatory approval, which constitutes an executive appointment under Item 5.02 equivalent disclosure for a foreign private issuer.
View raw filing on EDGAR →The 6-K discloses multiple executive and board changes effective August 2, 2026: appointment of Mr. Yongxin Su as director and Co-Chief Executive Officer, Ms. Bihua Liu as director and Co-Chief Financial Officer, Mr. Lei Yao as independent director and nominating committee chair, and Mr. Shipu Huang as independent director. While two directors also resigned (Zhang and Qian), the principal disclosed actions are the four new appointments to key governance and executive roles, making this an exec_appointment event. The appointments of two Co-CEOs and a Co-CFO are material to investor assessment of leadership and control.
View raw filing on EDGAR →